Biotechnology & Medical Research
Human Metabolome Technologies Inc:To set up a Yokohama-based wholly owned subsidiary on Jan. 21, 2016.The new subsidiary with registered capital of 50 million yen to be engaged in production and sale of medical equipment for drug testing.
Alnylam Pharmaceuticals Inc and Collaborators Report First-Ever Evidence that Patisiran Reduces Pathogenic
Alnylam Pharmaceuticals Inc:Alnylam and collaborators report first-ever evidence that patisiran reduces pathogenic, misfolded transthyretin monomers.Patisiran achieves an approximately 90% reduction in misfolded non-native conformations of ttr as measured in serum.
Biocon Ltd:Says inaugurated a world class facility for manufacturing new generaion patient-friendly devices for its insulines portfolio.
OncoTherapy Science Inc:Started TCR (T Cell Receptor) analysis business.
Beijing Strong Biotechnologies Inc:Invested 10 mln yuan and established a wholly owned medical diagnostic products subsidiary in Beijing.
Pharma Foods International Co Ltd:To establish a new subsidiary located in Fukuoka in August.Says the new subsidiary will be engaged in call center business.Says the company will hold a 75 pct stake, an individual will hold a 20 pct stake and another company will hold a 5 pct stake respectively in the new subsidiary.New subsidiary to be capitalized at 10 million yen.
TSO3 Inc:Says formation of a wholly owned subsidiary: TSO3Corporation in the State of South Carolina, USA.Says new location is expected to open in August of this year in time to meet US customer requirements.
Guangzhou Boji Medical and Biotechnological Co Ltd:Says establishment of a wholly owned subsidiary in Lhasa, with a registered capital of 30 million yuan.The new subsidiary will be engaged in investment management.